![Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01042-7/MediaObjects/41392_2022_1042_Fig1_HTML.png)
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
![Introducing PIONEER: a project to harness big data in prostate cancer research | Nature Reviews Urology Introducing PIONEER: a project to harness big data in prostate cancer research | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-020-0324-x/MediaObjects/41585_2020_324_Fig1_HTML.png)
Introducing PIONEER: a project to harness big data in prostate cancer research | Nature Reviews Urology
![ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study](https://www.urotoday.com/images/Rathkopf_Study_Schema.png)
ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study
![Prostate Cancer Clinical Trial Consortium (PCCTC) and Sorrento Therapeutics, Inc : r/BANDOFBROTHERSOFSRNE Prostate Cancer Clinical Trial Consortium (PCCTC) and Sorrento Therapeutics, Inc : r/BANDOFBROTHERSOFSRNE](https://external-preview.redd.it/CVAu4L0jR8Ve14YD6MoqvSj2ec1RxKSn7TXHzw6Bqg0.jpg?width=640&crop=smart&auto=webp&s=5e6db1f8e63b031c68c2df1a3e13055affa93eef)
Prostate Cancer Clinical Trial Consortium (PCCTC) and Sorrento Therapeutics, Inc : r/BANDOFBROTHERSOFSRNE
![Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry | JCO Global Oncology Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry | JCO Global Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/go/2021/go.2021.7/go.20.00571/20210407/images/large/go.20.00571t2.jpeg)
Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry | JCO Global Oncology
![Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling](https://mma.prnewswire.com/media/830740/Caris_Life_Sciences_Logo.jpg?w=200)
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
![Advancing Prostate Cancer Research - The Prostate Cancer Clinical Trials Consortium (PCCTC) - Sarah Wise Advancing Prostate Cancer Research - The Prostate Cancer Clinical Trials Consortium (PCCTC) - Sarah Wise](https://cf-images.us-east-1.prod.boltdns.net/v1/jit/2579504123001/e49fcf61-24e5-4b94-af91-010d2b611886/main/1280x720/4m6s378ms/match/image.jpg)
Advancing Prostate Cancer Research - The Prostate Cancer Clinical Trials Consortium (PCCTC) - Sarah Wise
![Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News](https://www.karmanos.org/Uploads/Public/Images/Karmanos/News/heath-elizabeth.jpg)
Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News
![PDF) Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium | Mitchell Gross - Academia.edu PDF) Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium | Mitchell Gross - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40044291/mini_magick20190222-21895-exx168.png?1550823876)